Pediatrix Medical Group Inc (MD) Stock Analysis
Verdict: HOLD
Margin recovery and debt reduction provide a valuation floor, but stagnant top-line growth and neutral analyst sentiment limit upside.
Investment score: 64/100
Analysis as of
Is Pediatrix Medical Group Inc stock worth reviewing? AI model thesis
Pediatrix shows strong operational recovery with an 8.4% earnings yield, but sits at full valuation relative to short-term targets.
7-factor investment score
- Valuation: 75/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 55/100 (weight 15%)
- Earnings Quality: 80/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 70/100 (weight 15%)
Pediatrix Medical Group Inc opportunities and risks
What speaks for MD
- Significant Free Cash Flow Generation
What speaks against MD
- Demographic Birth Rate Headwinds
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MD | 12.5x | 1.1x | 9.3x | 25.9% | 9.0% | 10.6% |
| AVAH | 9.6x | 1.1x | 13.9x | 32.0% | 10.6% | 6.0% |
| PRVA | 95.6x | 1.1x | n/a | 7.6% | 1.2% | -1.8% |
| GRDN | 36.2x | 1.6x | 20.6x | 21.6% | 4.5% | 3.3% |
| PINC | 60.4x | 0.0x | 1.5x | 73.0% | 9.4% | 699.1% |
| ADUS | 20.2x | 1.5x | 12.9x | 32.4% | 7.1% | 7.1% |
| Peer median | 36.2x | 1.1x | 12.9x | 32.0% | 7.1% | 6.0% |
Frequently asked questions about Pediatrix Medical Group Inc (MD)
Is MD stock a good investment?
The cached TradeMates AI model rates Pediatrix Medical Group Inc as HOLD with an investment score of 64/100. Pediatrix shows strong operational recovery with an 8.4% earnings yield, but sits at full valuation relative to short-term targets. This is algorithmic model output, not personal investment advice.
Is MD stock a buy?
The TradeMates model verdict for MD is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.